DKSH has announced  that it signed an agreement to acquire Eppendorf’s direct business in Thailand. Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world and employs around 4,500 people in more than 30 countries.

In Thailand, Eppendorf is a local market leader for liquid handling (pipettes), centrifuges, and general laboratory equipment. The transaction includes the takeover of Eppendorf (Thailand) Co., Ltd. employees, as well as an exclusive right to distribute Eppendorf’s products in Thailand. Through this transaction, DKSH will further solidify its position as a leading market expansion services provider in the field of Scientific Solutions in Asia and beyond.

Hanno Elbraechter, Head, Business Unit Technology at DKSH, said: “We are delighted to see Eppendorf Thailand join our operations. This step highlights the continued outsourcing trend adopted by numerous multinational companies aiming to focus more on their strategic core capabilities, that will benefit DKSH. Eppendorf’s portfolio consists of highly competitive instruments, services, and consumables and is complementary to ours in the region. Through our capillary distributor and customer network, we will jointly be able to expand in high-growth segments such as food & beverage, biotech, and pharma.”

Wilson Wang, Senior Vice President Asia Pacific China at Eppendorf Group, commented: “We are excited to start this new chapter with DKSH. With this transaction, we are combining the local strengths of DKSH with Eppendorf’s strong brand and premium reliable products. We are confident DKSH will successfully develop the business and are convinced this step is beneficial for our own business, our business partners and customers, as well as our valued employees.”

The closing of the transaction is expected during the third quarter of 2025 and is subject to certain conditions.